Expression of the 5-HT(1B) receptor by subtypes of rat trigeminal ganglion cells

Neuroscience

Volumn 95, Issue 2, 1999, Pages 465-471

  Wotherspoon, G ^a   Priestley, J V ^a  

^a Neuroscience Section   (United Kingdom)

Author keywords

CGRP; Migraine; Nociceptive; Rat; trkA; Vasodilation

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; SEROTONIN; SEROTONIN 1B RECEPTOR; SUBSTANCE P; BIOLOGICAL MARKER; COLORING AGENT; GRIFFONIA SIMPLICIFOLIA LECTINS; LECTIN; MESSENGER RNA; NEUROFILAMENT PROTEIN; NEUROFILAMENT PROTEIN H; PLANT LECTIN; PROTEIN TYROSINE KINASE A; SEROTONIN RECEPTOR; TOLONIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOREACTIVITY; MALE; MIGRAINE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRIGEMINUS GANGLION; VASODILATATION; ANIMAL; CHEMISTRY; GENE EXPRESSION; GENETICS; IN SITU HYBRIDIZATION; MYELINATED NERVE; NOCICEPTIVE RECEPTOR; PATHOPHYSIOLOGY; PHYSIOLOGY; SENSORY NERVE CELL; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; CALCITONIN GENE-RELATED PEPTIDE; COLORING AGENTS; GENE EXPRESSION; IN SITU HYBRIDIZATION; LECTINS; MALE; MIGRAINE DISORDERS; NERVE FIBERS, MYELINATED; NEUROFILAMENT PROTEINS; NEURONS, AFFERENT; NOCICEPTORS; PLANT LECTINS; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, TRKA; RECEPTORS, SEROTONIN; RNA, MESSENGER; SUBSTANCE P; TOLONIUM CHLORIDE; TRIGEMINAL GANGLION; VASODILATION;

EID: 0033630246     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00465-0     Document Type: Article

References (41)

1. Alvarez F.J., Morris H.R., Priestley J.V. Sub-populations of smaller diameter trigeminal primary afferent neurons defined by expression of calcitonin gene-related peptide and the cell surface oligosaccharide recognized by monoclonal antibody LA4. J. Neurocytol. 20:1991;716-731.
2. Averill S., McMahon S.B., Clary D.O., Reichardt L.F., Priestley J.V. Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons. Eur. J. Neurosci. 7:1995;1484-1494.
3. Beattie D.T., Connor H.E., Hagan R.M. Recent developments in tachykinin NK1 receptor antagonists - prospects for the treatment of migraine headache. Can. J. Physiol. Pharmac. 73:1995;871-877.
4. 1D receptor mRNA differential co-localization with peptide mRNA in the guinea pig trigeminal ganglion. NeuroReport. 9:1998;641-645.
5. Bonvento G., MacKenzie E.T., Edvinsson L. Serotonergic innervation of the cerebral vasculature: relevance to migraine and ischaemia. Brain Res. Rev. 16:1991;257-263.
6. Branchek T. A., Zgombick J. M., Kucharewicz S. A., Gustafson E. L., Durkin M. M., Bard J. A. and Weinshank R. L. (1996) Molecular perspectives on serotonin receptor subtypes in experimental models of migraine. In Towards Migraine 2000 (ed. Clifford Rose F.), pp. 247-256. Elsevier, Amsterdam.
7. 1F receptor messenger RNA in rodent and primate brain. Neuropharmacology. 33:1994;367-386.
8. 1B receptor messenger RNA in neurons of the rat trigeminal ganglia. Eur. J. Pharmac. 227:1992;357-359.
9. 1B receptor messenger RNA in rat brain and trigeminal ganglia. Br. J. Pharmac. 108:1993;95.
10. Edvinsson L., Degueurce A., Duverger D., MacKenzie E.T., Scatton B. Central serotonergic nerves project to the pial vessels of the brain. Nature. 306:1983;55-57.
11. Edvinsson L., Goadsby P.J. Neuropeptides in headache. Eur. J. Neurol. 5:1998;329-341.
12. Edvinsson L., Hara H., Uddman R. Retrograde tracing of nerve fibers to the rat middle cerebral artery with true blue - colocalization with different peptides. J. cerebr. Blood Flow Metab. 9:1989;212-218.
13. Ferrari M.D., Saxena P.R. Clinical and experimental effects of sumatriptan in humans. Trends pharmac. Sci. 14:1993;129-133.
14. Gallai V., Sarchielli P., Floridi A., Franceschini M., Codini M., Glioti G., Trequattrini A., Palumbo R. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia. 15:1995;384-390.
15. Goadsby P.J., Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neurol. 33:1993;48-56.
16. Hamel E., Fan E., Linville D., Ting V., Villemure J.G., Chia L.S. Expression of messenger-RNA for the serotonin 5-hydroxytryptamine (1D-beta) receptor subtype in human and bovine cerebral arteries. Molec. Pharmac. 44:1993;242-246.
17. Humphrey P.P.A., Feniuk W. Mode of action of the antimigraine drug sumatriptan. Trends pharmac. Sci. 12:1991;444-446.
18. Hunt S. P., Mantyh P. W. and Priestley J. V. (1992) The organization of biochemically characterized sensory neurons. In Sensory Neurons. Diversity, Development, and Plasticity (ed. Scott S. A.), pp. 60-76. Oxford University Press, New York.
19. 1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs. NeuroReport. 8:1997;2237-2240.
20. Lawson S. N. (1992) Morphological and biochemical cell types of sensory neurons. In Sensory Neurons. Diversity, Development, and Plasticity (ed. Scott S. A.), pp. 27-59. Oxford University Press, New York.
21. Lawson S.N., Waddell P.J. Soma neurofilament immunoreactivity is related to cell size and fibre conduction velocity in rat primary sensory neurons. J. Physiol. 435:1991;41-63.
22. Lee Y., Kawai Y., Shiosaka S., Takami K., Kiyama H., Hillyard C.J., Girgis S., Macintyre I., Emson P., Tohyama M. Coexistence of CGRP and substance P-like peptides in single cells of the trigeminal ganglia of the rat: immunohistochemical analysis. Brain Res. 330:1985;194-196.
23. 1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia. 17:1997;833-842.
24. Michael G.J., Averill S., Nitkunan A., Rattray M., Bennett D.L.H., Yan Q., Priestley J.V. Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in trkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J. Neurosci. 17:1997;8476-8490.
25. Michael G. J. and Priestley J. V. (1996) Combined immunocytochemsitry and in situ hybridization. In In Situ Hybridization Techniques for the Brain (ed. Henderson Z.), pp. 111-118. Wiley, Chichester.
26. Michael G.J., Priestley J.V. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J. Neurosci. 19:1999;1844-1854.
27. Moskowitz M.A. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends pharmac. Sci. 13:1992;307-311.
28. O'Connor T.P., van der Kooy D. Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J. Neurosci. 8:1998;2468-2476.
29. Pierce P.A., Xie G.X., Meuser T., Peroutka S.J. 5-hydroxytryptamine receptor subtype messenger RNAs in human dorsal root ganglia: a polymerase chain reaction study. Neuroscience. 81:1997;813-819.
30. Priestley J. V. (1996) Neurochemistry of neuronal pathways implicated in the pathogenesis of migraine. In Towards Migraine 2000 (ed. Clifford Rose F.), pp. 185-198. Elsevier, Amsterdam.
31. Priestley J.V., Wotherspoon G., Savery D., Averill S., Rattray M. A combined in situ hybridization and immunofluorescence procedure allowing visualisation of peptide mRNA and serotonin in single sections. J. Neurosci. Meth. 48:1993;99-110.
32. 1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development. Proc. natn. Acad. Sci. U.S.A. 91:1994;3666-3669.
33. Ruda M.A., Coffield J., Steinbusch A.W. Immunocytochemical analysis of serotonergic axons in laminae I and II of the lumbar spinal cord of the cat. J. Neurosci. 2:1982;1660-1671.
34. Saito K., Liu-Chen L.Y., Moskowitz M.A. Substance P-like immunoreactivity in rat leptomeninges and cerebral vessels originates from the trigeminal but not sympathetic ganglia. Brain Res. 403:1987;66-71.
35. Sandler M. Migraine to the year 2000. Cephalalgia. 15:1995;259-264.
36. 1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats. Neuropharmacology. 36:1997;525-533.
37. Silverman J.D., Kruger L. Lectin and neuropeptide labeling of separate populations of dorsal root ganglion neurons and associated "nociceptor" thin axons in rat testis and cornea whole-mount preparations. Somatosensory Res. 5:1988;259-267.
38. Smith G.S., Savery D., Marden C., Lopez Costa J.J., Averill S., Priestley J.V., Rattray M. Distribution of messenger RNAs encoding enkephalin, substance P, somatostatin, galanin, vasoactive intestinal polypeptide, neuropeptide Y, and calcitonin gene-related peptide in the midbrain periaqueductal grey in the rat. J. comp. Neurol. 350:1994;23-40.
39. Snider W.D., McMahon S.B. Tackling pain at the source: new ideas about nociceptors. Neuron. 20:1998;629-632.
40. Voigt M.M., Laurie D.J., Seeburg P.H., Bach A. Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine1B receptor. Eur. molec. Biol. Org. J. 10:1991;4017-4023.
41. Zagami A.S., Goadsby P.J., Edvinsson L. Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides. 16:1990;69-75.